Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Clinical Trials

30 clinical trials for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis — RECRUITING · PHASE2
• Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis — RECRUITING · PHASE3
• An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases — RECRUITING · PHASE1
• A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases — RECRUITING · PHASE1
• A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases — RECRUITING · PHASE1
• Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases — RECRUITING · PHASE1
• Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases — RECRUITING · PHASE1
• A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases — RECRUITING · PHASE1
• Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) — RECRUITING · PHASE1
• An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease — RECRUITING · NA
• Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease — RECRUITING · PHASE1
• Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease — ACTIVE_NOT_RECRUITING · PHASE3
• A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases — NOT_YET_RECRUITING · NA
• Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) — ACTIVE_NOT_RECRUITING · PHASE1
• An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases — ACTIVE_NOT_RECRUITING · PHASE1
• Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) — NOT_YET_RECRUITING · PHASE2
• Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease. — COMPLETED
• Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases — OTHER · PHASE1
• A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy Participants — COMPLETED · PHASE1
• A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications — COMPLETED · PHASE1
• A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168 — COMPLETED · PHASE1
• A Study of CCX168 in Japanese and Caucasian Healthy Adult Males — COMPLETED · PHASE1
• Stratified Therapy on Pediatric AAGN — OTHER · PHASE4
• Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing — TERMINATED · PHASE4
• Rituximab Vasculitis Maintenance Study — COMPLETED · PHASE3
• Low-dose Glucocorticoid Vasculitis Induction Study — OTHER · PHASE4
• The Clinical Efficacy of DFPP in Patients With AAGN — TERMINATED · NA
• Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens — WITHDRAWN · PHASE2
• Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab — WITHDRAWN · PHASE2
• Differing Levels of Positive Anti-Neutrophil Cytoplasm Antibody (ANCA) Test and Their Correlation With Vasculitis or Malignancy or Chronic Inflammation — OTHER

Refine this search